Day: ខែកញ្ញា 17, 2025

sureWin Partners with Daesung and the Black Eyed Peas in Landmark Month for Asian Music
A groundbreaking month of music and culture sees sureWin partner with global icons, offering fans exclusive experiences and shaping the future of live entertainment in Asia
Kuala Lumpur, Malaysia – 2025 – In a rare feat for Asia’s live entertainment industry, sureWin has become the only regional brand this year to partner with both a top K-pop idol and a global pop group within the same month. The company first joined forces with Daesung, one of K-pop’s most celebrated vocalists, before extending its reach to collaborate with the Black Eyed Peas, the iconic American group known for their global chart-topping hits. These back-to-back partnerships highlight sureWin’s growing influence in shaping Asia’s entertainment landscape through high-profile international collaborations.
The back-to-back announcements attracted attention from industry observers who noted the rarity of aligning with two international headliners in such close succession. In an entertainment market......

ទីផ្សារដំណើរកម្សាន្តឈានមុខគេ WINGIE ចែករំលែកការវិភាគអំពីតម្រូវការធ្វើដំណើរ នៅពេលទិវាជាតិអារ៉ាប៊ីសាអូឌីតឆ្នាំ ២០២៥ ជិតមកដល់
(SeaPRwire) - ដូបៃ សហភាពអារ៉ាប់អេមីរ៉ាត និង រីយ៉ាដ អារ៉ាប៊ីសាអូឌីត ថ្ងៃទី ១៧ ខែកញ្ញា ឆ្នាំ ២០២៥ -- ខណៈដែលអារ៉ាប៊ីសាអូឌីតប្រារព្ធទិវាជាតិលើកទី ៩៥ របស់ខ្លួននៅថ្ងៃទី ២៣ ខែកញ្ញ......

Ultraman Card Game Original Illustration of “Alien Metron” By Manga Artist Yukinobu Tatsu to be Included in the Upcoming Booster Pack Release
KUALA LUMPUR, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Tsuburaya Productions Co., Ltd. unveils an original illustration for the Ultraman Card Game by Yukinobu Tatsu, the manga artist behind the popular series “DAN DA DAN” that is currently being serialized in Shonen Jump+. Featuring the iconic character “Alien Metron The Hallucination Alien,” this artwork will appear on a promotional card for an upcoming product. This information was released at TSUBURAYA CONVENTION 2025, held on 13 & 14 September at Tokyo Dome City.■「Alien Metron The Hallucination Alien」The illustration depicts Alien Metron dashing through a city at dusk—eerie, yet full of humorous charm. This card will be distributed as a purchase bonus for Booster Pack Vol. 5 “Heroes of the Radiant Dawn” on 31 October 2025.Additionally, a new product type will be released on Friday, December 19, 2025. Titled “Ultra Deck 01 Ultraman Tiga & Ultraman Blazar,” this prod......

Professor Lin Xiang Xiong Hosts Landmark Art Exhibition and Peace Prize Ceremony in Paris
“The Vicissitudes of Life” Celebrates the Transformative Power of Art in Dialogue, Reflection and PeacebuildingPENANG, Malaysia, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Renowned humanitarian-artist Professor Lin Xiang Xiong (“Professor Lin”) and founder of the Lin Xiang Xiong Art Gallery in Penang, presented his latest exhibition, “The Vicissitudes of Life”, at the historic Hôtel de l’Industrie in Paris from 10 to 13 September 2025.(L-R) Jean-Pierre Raffarin, former French Prime Minister and founder of Lin Xiang Xiong Art Gallery, Professor Lin Xiang XiongThe exhibition received strong support from key French institutions, with former French President François Hollande serving as Honorary Patron, and former French Prime Minister Jean-Pierre Raffarin personally attending the opening. Featuring 25 original works by Professor Lin, the exhibition explored three themes - anti-war, anti-poverty, and anti-pollution - and vividly embodied Professor Lin......

ឃាត់ខ្លួនមនុស្ស ៤ នាក់បន្ទាប់ពីរូបថតរបស់ Trump និង Epstein ត្រូវបានគេបាញ់បញ្ចាំងលើ Windsor Castle
(SeaPRwire) - ហេតុការណ៍នេះបានកើតឡើងនៅពេលដែលប្រធានាធិបតីអាមេរិកបានមកដល់សម្រាប់ការបំពេញទស្សនកិច្ចផ្លូវរដ្ឋនៅចក្រភពអង់គ្លេស
ប៉ូលីសចក្រភពអង់គ្លេសបានចាប់ខ្ល......

Karbon-X Corp. Files Year-End Financial Results
Calgary, Canada, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - Karbon-X Corp. (OTCQX:KARX) (“Karbon-X" or the “Company”), a vertically integrated climate solutions company, today announced that it has filed its Form 10-K with audited financial results for the fiscal year ended May 31, 2025.The full filing is available under the Company’s profile on OTC Markets at www.otcmarkets.com/stock/KARX/overview Operational and Strategic highlights for Fiscal Year 2025Completed the acquisition of ALLCOT Group, expanding Karbon-X’s global footprint and integrating world-class expertise.Launched trading operations, marking a critical milestone in validating the Company’s business model and initiating its revenue-generating activities. Entered landmark partnerships with major energy producers and with the BK Dukes, reflecting strong market confidence in Karbon-X’s vision and capabilities.Financial Highlights for Fiscal Year 2025 Revenue surged to $3.......

EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
HONG KONG, Sep 17, 2025 - (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that data from the Phase 3 SYMPHONY 2 trial evaluating the safety and efficacy of HTD1801 in patients with type 2 diabetes mellitus (T2DM) is being presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.HTD1801, is a first-in-class anti-inflammatory metabolic modulator that activates AMPK and inhibits the NLRP3 inflammasome. These pathways converge at the nexus of metabolic dysregulation beyond glucose control and chronic inflammation. This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of HTD1801 compared to placebo in patients with T2DM inadequately controlled with metformin. The primary endpoint of Symphony 2 was change from baseline in HbA1c to We......

EASD 2025 | HighTide Therapeutics Announces Oral Presentation of Phase 3 Data in Patients with Type 2 Diabetes
HONG KONG, Sep 17, 2025 - (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for metabolic diseases, announced that data from the Phase 3 SYMPHONY 2 trial evaluating the safety and efficacy of HTD1801 in patients with type 2 diabetes mellitus (T2DM) is being presented at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna.HTD1801, is a first-in-class anti-inflammatory metabolic modulator that activates AMPK and inhibits the NLRP3 inflammasome. These pathways converge at the nexus of metabolic dysregulation beyond glucose control and chronic inflammation. This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of HTD1801 compared to placebo in patients with T2DM inadequately controlled with metformin. The primary endpoint of Symphony 2 was change from baseline in HbA1c to We......

TruMerit Adds Two More Global Credentials for Rehabilitation Care Workers
PHILADELPHIA, PA, Sept 17, 2025 - (ACN Newswire via SeaPRwire.com) - TruMerit, a global leader in healthcare workforce development, today launched two new global credentials for healthcare workers specializing in rehabilitation, habilitation, and restorative care.The Certified Global Health Worker-Rehabilitation (CGHW-R) and the Certified Global Health Worker-Rehabilitation Advanced (CGHW-RA) have been developed specifically for eligible health workers worldwide who wish to have their applied experience and competencies in rehab care recognized and verified by passing a certification examination. These credentials, along with the Certified Global Nurse-Rehabilitation (CGN-R) that TruMerit established last year, are intended to advance and improve services for the more than two billion people worldwide who need this care.The CGHW-RA credential was developed for those with a degree or diploma in a rehabilitation field. These include clinicians, educators, and instructors with physiotherapy, ......